STVN/N fundamentals
STEVANATO GROUP S.P.A. revenue breakdown overview
STEVANATO GROUP S.P.A. revenue for the last year amounted to 23.83 B MXN, the most of which — 21.06 B MXN — came from its highest performing source at the moment, Biopharmaceutical and Diagnostic Solutions, the year earlier bringing 16.15 B MXN. The greatest contribution to the revenue figure was made by EMEA — last year it brought STEVANATO GROUP S.P.A. 15.06 B MXN, and the year before that — 11.64 B MXN.
By source
2019
2020
2021
2022
2023
2024
0.00
7.00 B
14.00 B
21.00 B
28.00 B
Biopharmaceutical and Diagnostic Solutions
Engineering
Currency: MXN
2019
2020
2021
2022
2023
2024
Biopharmaceutical and Diagnostic Solutions
12.83 B
16.85 B
16.39 B
16.15 B
21.06 B
Engineering
2.21 B
3.64 B
3.77 B
3.78 B
3.84 B
By country
2019
2020
2021
2022
2023
2024
0.00
7.00 B
14.00 B
21.00 B
28.00 B
EMEA
North America
APAC
South America
Currency: MXN
2019
2020
2021
2022
2023
2024
EMEA
9.04 B
11.98 B
12.29 B
11.64 B
15.06 B
North America
3.97 B
5.02 B
5.14 B
5.83 B
6.97 B
APAC
1.52 B
2.86 B
2.06 B
1.89 B
2.17 B
South America
496.15 M
624.78 M
674.41 M
567.41 M
699.13 M